After the dismissal of the federal MDL in August, plaintiffs’ lawyers have turned to appeal as their last option. We will provide updates on the appellate filing as soon as new details emerge. Meanwhile, several state-level cases are still ongoing, particularly in Illinois and California. In these cases, Johnson & Johnson has filed motions to dismiss based on federal preemption. We will continue to update this page as those rulings are issued. The California case is scheduled for trial in April 2025.
[fluentform id=”15″]
